InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the ” Genetically Engineered Animal Models & Services Market– (By type of services (Custom Model Development, Consultation Services, Model Validation, Breeding Services, Maintenance Services), by application (Oncology, Immunology, Metabolic Disorders, Cardiovascular Diseases, Neurological Disorders), and by end-user (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes, Government Organizations)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034.”
According to the latest research by InsightAce Analytic, the Genetically Engineered Animal Models & Services Market is valued at USD 1.4 Bn in 2024, and it is expected to reach USD 3.8 Bn by the year 2034, with a CAGR of 10.3 % during the forecast period of 2025-2034.
Check this Report Brochure : https://www.insightaceanalytic.com/request-sample/3043
Genetically engineered animal models serve as vital tools in biomedical research, enabling the exploration of gene function, disease pathogenesis, and the development of innovative therapeutic approaches. Utilizing cutting-edge genetic modification techniques—such as CRISPR-Cas9 and transgenesis—these models are designed to mimic human disease states with high fidelity. Specialized service providers, including Charles River Laboratories, offer a broad range of support services encompassing model creation, colony management, cryopreservation, phenotypic analysis, and drug efficacy testing.
The growth of this market is primarily driven by the rising global burden of chronic diseases, increased investment in research and development activities, and ongoing progress in genetic engineering technologies. Genetically modified organisms, especially murine models, are widely adopted in oncology research to investigate tumorigenesis, disease progression, and metastasis. Furthermore, the expanding R&D budgets of biotechnology and pharmaceutical companies are fueling demand for genetically engineered models and related services, thereby advancing the development of precision medicine and targeted therapeutic solutions.
List of Prominent Players in the Genetically Engineered Animal Models & Services Market:
- Charles River Laboratories
- Envigo
- GenOway
- Celerion
- Crown Bioscience
- Horizon Discovery
- Crown Bioscience
- Jackson Laboratory
- Taconic Biosciences
- In Vivo Therapeutics
- BioIVT
- Celerion
Market Dynamics
Drivers:
The market for genetically engineered animal models and associated services is undergoing significant growth, primarily fueled by advancements in gene-editing technologies, particularly the CRISPR/Cas9 system. This cutting-edge tool enables precise and efficient modification of animal genomes, thereby accelerating the development of complex and disease-specific models. According to data from the National Human Genome Research Institute (NHGRI), scholarly interest in CRISPR has surged, with published research increasing from approximately 100 articles in 2012 to over 16,000 by 2020, underscoring the widespread adoption of this technology. Moreover, the rising demand for humanized animal models—incorporating human genetic material, cells, or tissues—continues to expand, as these models offer enhanced translational relevance in preclinical studies, particularly within immuno-oncology, regenerative medicine, and infectious disease research.
Challenges:
Despite the positive outlook, the market faces notable constraints. One of the primary barriers is the high cost associated with generating and maintaining genetically modified animal models. These procedures require sophisticated techniques, such as embryo manipulation, controlled breeding, and genome editing, all of which necessitate significant capital investment in infrastructure, specialized technology, and highly trained personnel. Such financial demands can be prohibitive for smaller institutions and academic researchers. In addition, ethical considerations regarding the welfare of genetically modified animals remain a persistent challenge. Public and organizational concerns over animal rights and experimental practices continue to influence regulatory discussions and research practices.
Regional Trends:
North America is expected to retain a dominant position in the global market, supported by a mature life sciences ecosystem that includes leading universities, advanced research institutes, and a strong presence of biopharmaceutical companies with substantial R&D investments. The region’s infrastructure and regulatory support contribute to its continued leadership in genetically engineered animal model development. Conversely, the Asia-Pacific region is poised for the most rapid growth during the forecast period. This expansion is being driven by a surge in life sciences research activity, increasing public and private investment, and the establishment of regulatory frameworks that support ethical and scientific rigor in the use of genetically modified animals. Countries across the region are actively fostering innovation while ensuring responsible compliance with bioethical standards, creating favorable conditions for sustained market growth.
Segmentation of Genetically Engineered Animal Models & Services Market-
By Type of Services-
- Custom Model Development
- Consultation Services
- Model Validation
- Breeding Services
- Maintenance Services
By Application-
- Oncology
- Immunology
- Metabolic Disorders
- Cardiovascular Diseases
- Neurological Disorders
By End-User-
- Biotechnology Companies
- Pharmaceutical Companies
- Contract Research Organizations
- Academic and Research Institutes
- Government Organizations
By Region-
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
